VANCOUVER, BC / ACCESSWIRE / October 26, 2020 / The Board of Directors of Experion Holdings Ltd. (the “Corporation” or “Experion”) (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) and CEO Mr. Jarrett Malnarich are pleased to announce the appointment of Mr. Kerry Biggs to the position of Chief Financial Officer commencing October 23 2020, replacing Interim CFO, Mr. Sean McNeil, who remains Chairman of the Board of Experion.
“We are very excited to welcome Mr. Biggs to Experion as our new CFO” said Jarrett Malnarich, CEO of Experion. “Kerry has more than 20 years of finance and business experience, which will support our operations and growth plans. Most recently Kerry served as the CFO of a publicly traded company within the Canadian cannabis sector, and prior to that, as a financial executive at Lululemon Athletica, where he was Vice President, Treasurer looking after corporate finance, capital structure and insurance. Prior to that, he has served in other financial executive roles responsible for a breadth of financial activities including financial reporting and administration, risk, tax planning, financial planning and analysis and corporate M&A activities.”
“Joining Experion is a unique and exciting opportunity for me, as the company continues its leadership position in the Canadian market with its premium cannabis brand: Citizen Stash”, said Kerry Biggs, Chief Financial Officer of Experion. “I am looking forward to helping the team tell the story to the market of the tremendous growth opportunity that we have as a result of our premium line of products and the scale of our distribution capabilities across Canada”.
Mr. Biggs holds an MBA from the Richard Ivey School of Business (University of Western Ontario), a Chartered Professional Accountant designation, and a Bachelor of Arts, Political Science degree from the University of Victoria.
The Company also announced it has granted stock options to officers and employees to purchase up to 700,000 common shares, exercisable at a price of $0.15 cents per share. The stock options are exercisable for three years, until October 22, 2023.
About Experion Holdings Ltd.
Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC.
Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs’ including Adult-use, Wellness and Therapeutic, and Medical products.
Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “EXP” on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”
For further information, please visit the Company’s website www.experionwellness.com or contact Investor Relations, Email: IR@experionwellness.com
This news release contains “forward-looking statements” and “forward-looking information” (collectively referred to herein as “forward-looking statements”) within the meaning of applicable securities legislation. Such forward-looking statements include, without limitation, forecasts, estimates, expectations and objectives for future operations that are subject to a number of material factors, assumptions, risks and uncertainties, many of which are beyond the control of the Company.
Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects”, “plans”, “anticipates”, “believes”, “intends”, “estimates”, “continues”, “future”, “forecasts”, “potential”, “outlook” and similar expressions, or are events or conditions that “will”, “would”, “may”, “likely”, “could”, “should”, “can”, “typically”, “traditionally” or “tends to” occur or be achieved. This news release contains forward-looking statements, pertaining to, among other things, the following: The Company’s capital spending forecast and expectations of how it will be funded; near-term impacts from the COVID-19 pandemic; the Company’s capital management strategy and financial position; the impact of governmental and Company measures implemented in response to the COVID-19 pandemic; the Company’s outlook, activity levels, supply chains and sales channels; loss of markets; further legislative and regulatory developments involving cannabis or otherwise affecting the Company’s business or its consumers generally, including delays in the issuance of licenses; competition; currency and interest rate fluctuations; and marketing costs.
Although the Company believes that the material factors, expectations and assumptions expressed in such forward-looking statements are reasonable based on information available to it on the date such statements are made, undue reliance should not be placed on the forward-looking statements because the Company can give no assurances that such statements and information will prove to be correct and such statements are not guarantees of future performance. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties.
Actual performance and results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to: known and unknown risks, including those set forth in the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis (“MD&A”) (a copy of which can be found under Experion’s profile on SEDAR at www.sedar.com); a significant expansion of COVID-19 pandemic and the impacts thereof; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategy; integration of acquisitions, competition, and uncertainties resulting from potential delays or changes in plans with respect to acquisitions, development projects or capital expenditures and changes in legislation; stock market volatility and the inability to access sufficient capital from external and internal sources; general economic, market or business conditions including those in the event of an epidemic, natural disaster or other event; global economic events; changes to the Company’s financial position and cash flow; the availability of qualified personnel, management or other key inputs; currency exchange fluctuations; changes in political and security stability; potential industry developments; and other unforeseen conditions which could impact the Company. Accordingly, readers should not place undue importance or reliance on the forward-looking statements. Readers are cautioned that the foregoing list of factors is not exhaustive and should refer to “Risk Factors” set out in the MD&A.
Statements, including forward-looking statements, contained in this news release are made as of the date they are given and the Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Experion Holdings Ltd.